Back to screener
Beryl Drugs Ltd.
₹23.69
▲ 0.48 (+2.07%) today
Latest quote · Yahoo Finance
Market Cap
₹12 Cr
P/E (TTM)
19.1
P/B
1.2
Book Value
₹19.51
ROE
6.3%
Div Yield
—
D/E
0.25
EPS (TTM)
₹1.24
52W High
₹27.60
52W Low
₹15.92
Sales Growth
+52.20%
Profit Growth
—
Day High
₹23.90
Day Low
₹22.30
Volume
905
Fundamentals refreshed 14 hr ago · Statements just now · Source: Yahoo Finance
Quick Take
- • Trading at 19.1× trailing earnings
- • Moderate ROE at 6.3%
- • Low leverage (D/E 0.25)
- • No dividend data
- • Operating margin 4.5% · Net margin 2.9%
- • Profit growth — YoY · Beta 0.08
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 7 | +40.00% | +40.00% |
| Operating Profit | 1 | +0.00% | +0.00% |
| Net Profit | 0 | -100.00% | — |
| EPS (₹) | 0.44 | -60.36% | +1000.00% |
OPM 8.9% · Net margin 3.0% · prev quarter OPM 26.1%
Shareholding Pattern
Numbers in percentages · Source: Yahoo Finance
Promoters / Insiders40.50%
Public & Others59.50%
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.
